Hematology, The First Affiliated Hospital of Shandong First Medical
University & Shandong Provincial Qianfoshan Hospital, No. 16766
Jingshi Road, Jinan 250014, Shandong Province, P.R. China.
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
MiR-140 and DNAJC3-AS1 have been demonstrated to play critical roles in
cancer biology, while their participation in acute myeloid leukemia
(AML) is unclear. This study aimed to explore the role of miR-140 and
DNAJC3-AS1 in AML.
Materials and Methods
|Figure 1. Analysis of the expression of DNAJC3-AS1 and miR-140 in AML patients and controls.|
|Figure 2. Analysis of the direct interaction between DNAJC3-AS1 and miR-140, and the subcellular location of DNAJC3-AS1.|
|Figure 3. Analysis of the role of miR-140 in the expression of DNAJC3-AS1.|
|Figure 4. Analysis of the role of DNAJC3-AS1 and miR-140 in the proliferation of HL60 and U937 cells.|
Ethics Approval and Consent to Participate